Repurposing ribosome-targeting antibiotics to overcome resistance to venetoclax in acute myeloid leukemia

被引：1
|
作者：
Sharon, David [1 ]
Chan, Steven M. [1 ]
机构：
[1] Princess Margaret Canc Ctr, Dept Hematol & Med Oncol, Toronto, ON, Canada
来源：
MOLECULAR & CELLULAR ONCOLOGY | 2020年 / 7卷 / 02期
基金：
加拿大健康研究院;
关键词：
Acute myeloid leukemia; BCL-2; inhibitor; drug resistance; integrated stress response; antibiotics; mitochondrial translation; ABT-199;
D O I：
10.1080/23723556.2020.1712182
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Venetoclax, a selective B-cell lymphoma 2 inhibitor, has shown promise in the treatment of acute myeloid leukemia. However, the development of drug resistance limits its clinical efficacy. In our study, we discovered that ribosome-targeting antibiotics can be repurposed to overcome venetoclax resistance in AML cells through activation of the integrated stress response.
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Effect of ribosome-targeting antibiotics on streptomycin-resistant Mycobacterium mutants in the rpsL gene
    Pelchovich, Gidi
    Zhuravlev, Alina
    Gophna, Uri
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2013, 42 (02) : 129 - 132
  • [42] Cell-free production of fluorescent proteins for the discovery of novel ribosome-targeting antibiotics
    Hoeger, Bastian
    Peifer, Christian
    Beitz, Eric
    JOURNAL OF MICROBIOLOGICAL METHODS, 2023, 213
  • [43] Ribosome-targeting antibiotics as inhibitors of oncogenic microRNAs biogenesis: Old scaffolds for new perspectives in RNA targeting
    Thi Phuong Anh Tran
    Duc Duy Vo
    Di Giorgio, Audrey
    Duca, Maria
    BIOORGANIC & MEDICINAL CHEMISTRY, 2015, 23 (17) : 5334 - 5344
  • [44] Synthesis and Evaluation of Hetero- and Homodimers of Ribosome-Targeting Antibiotics: Antimicrobial Activity, in Vitro Inhibition of Translation, and Drug Resistance
    Berkov-Zrihen, Yifat
    Green, Keith D.
    Labby, Kristin J.
    Feldman, Mark
    Garneau-Tsodikova, Sylvie
    Fridman, Micha
    JOURNAL OF MEDICINAL CHEMISTRY, 2013, 56 (13) : 5613 - 5625
  • [45] Venetoclax resistance in acute lymphoblastic leukemia is characterized by increased mitochondrial activity and can be overcome by co-targeting oxidative phosphorylation
    Enzenmueller, Stefanie
    Niedermayer, Alexandra
    Seyfried, Felix
    Muench, Vera
    Tews, Daniel
    Rupp, Ulrich
    Tausch, Eugen
    Gross, Alexander
    Fischer-Posovszky, Pamela
    Walther, Paul
    Stilgenbauer, Stephan
    Kestler, Hans A.
    Debatin, Klaus-Michael
    Meyer, Lueder Hinrich
    CELL DEATH & DISEASE, 2024, 15 (07):
  • [46] Acute Myeloid Leukemia Mutations and Future Mechanistic Target to Overcome Resistance
    Rehan Uddin
    Noureldian H. E. Darwish
    Shaker A. Mousa
    Current Treatment Options in Oncology, 2021, 22
  • [47] Acute Myeloid Leukemia Mutations and Future Mechanistic Target to Overcome Resistance
    Uddin, Rehan
    Darwish, Noureldian H. E.
    Mousa, Shaker A.
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2021, 22 (09)
  • [48] Targeting CREB-Binding Protein (CREBBP) Overcomes Resistance to Azacitidine and Venetoclax Therapy in Acute Myeloid Leukemia (AML)
    LeBlanc, Francis
    Bennett, Josh
    Choi, Kwangmin
    Starczynowski, Daniel T.
    BLOOD, 2023, 142
  • [49] Targeting Mitochondrial Translation Overcomes Venetoclax Resistance in Acute Myeloid Leukemia (AML) through Activation of the Integrated Stress Response
    Sharon, David
    Cathelin, Severine
    Subedi, Amit
    Williams, Ryan
    Benicio, Mariana
    Ketela, Troy
    Chan, Steven M.
    BLOOD, 2017, 130
  • [50] A Combined Histone Deacetylases Targeting Strategy to Overcome Venetoclax Plus Azacitidine Regimen Resistance in Acute Myeloid Leukaemia: Three Case Reports
    Wang, Bin-Ru
    Wan, Chao-Ling
    Liu, Song-Bai
    Qiu, Qiao-Cheng
    Wu, Tian-Mei
    Wang, Jun
    Li, Yan-Yan
    Ge, Shuai-Shuai
    Qiu, Yan
    Shen, Xiang-Dong
    Xue, Sheng-Li
    Li, Zheng
    FRONTIERS IN ONCOLOGY, 2021, 11
12345